Prospective clinical study of R-CMD therapy for indolent B-cell lymphoma and mantle cell lymphoma

Trial Profile

Prospective clinical study of R-CMD therapy for indolent B-cell lymphoma and mantle cell lymphoma

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2013

At a glance

  • Drugs Cladribine (Primary) ; Dexamethasone (Primary) ; Mitoxantrone (Primary) ; Rituximab (Primary)
  • Indications B cell lymphoma; Mantle-cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 29 Aug 2012 Planned number of patients changed from 20 to 30.
    • 29 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top